Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study

Wilko Spiering; Bryan Williams; Jan Van der Heyden; Monique van Kleef; Rob Lo; Jorie Versmissen; Adriaan Moelker; Abraham Kroon; Hannes Reuter; Gary Ansel; Gregg W. Stone; Mark Bates; CALM-FIM EUR Investigators

doi:10.1016/S0140-6736(17)32337-1

Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study

Wilko Spiering^*, Bryan Williams, Jan Van der Heyden, Monique van Kleef, Rob Lo, Jorie Versmissen, Adriaan Moelker, Abraham Kroon, Hannes Reuter, Gary Ansel, Gregg W. Stone, Mark Bates, CALM-FIM EUR Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2655-2661
Number of pages	7
Journal	Lancet
Volume	390
Issue number	10113
DOIs	https://doi.org/10.1016/S0140-6736(17)32337-1
Publication status	Published - 16 Dec 2017

Keywords

ACTIVATION THERAPY
RENAL DENERVATION
CONTROLLED-TRIAL
BLOOD-PRESSURE
DOUBLE-BLIND
STIMULATION
PLACEBO
DISEASE

Cite this

Spiering, W., Williams, B., Van der Heyden, J., van Kleef, M., Lo, R., Versmissen, J., Moelker, A., Kroon, A., Reuter, H., Ansel, G., Stone, G. W., Bates, M., & CALM-FIM EUR Investigators (2017). Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study. Lancet, 390(10113), 2655-2661. https://doi.org/10.1016/S0140-6736(17)32337-1

Spiering, Wilko ; Williams, Bryan ; Van der Heyden, Jan ; van Kleef, Monique ; Lo, Rob ; Versmissen, Jorie ; Moelker, Adriaan ; Kroon, Abraham ; Reuter, Hannes ; Ansel, Gary ; Stone, Gregg W. ; Bates, Mark ; CALM-FIM EUR Investigators. / Endovascular baroreflex amplification for resistant hypertension : a safety and proof-of-principle clinical study. In: Lancet. 2017 ; Vol. 390, No. 10113. pp. 2655-2661.

@article{08d95e18ef8547b598d90b9fbd9f4fcc,

title = "Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study",

keywords = "ACTIVATION THERAPY, RENAL DENERVATION, CONTROLLED-TRIAL, BLOOD-PRESSURE, DOUBLE-BLIND, STIMULATION, PLACEBO, DISEASE",

author = "Wilko Spiering and Bryan Williams and {Van der Heyden}, Jan and {van Kleef}, Monique and Rob Lo and Jorie Versmissen and Adriaan Moelker and Abraham Kroon and Hannes Reuter and Gary Ansel and Stone, {Gregg W.} and Mark Bates and {CALM-FIM EUR Investigators}",

year = "2017",

month = dec,

day = "16",

doi = "10.1016/S0140-6736(17)32337-1",

language = "English",

volume = "390",

pages = "2655--2661",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Science",

number = "10113",

}

Spiering, W, Williams, B, Van der Heyden, J, van Kleef, M, Lo, R, Versmissen, J, Moelker, A, Kroon, A, Reuter, H, Ansel, G, Stone, GW, Bates, M & CALM-FIM EUR Investigators 2017, 'Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study', Lancet, vol. 390, no. 10113, pp. 2655-2661. https://doi.org/10.1016/S0140-6736(17)32337-1

Endovascular baroreflex amplification for resistant hypertension : a safety and proof-of-principle clinical study. / Spiering, Wilko; Williams, Bryan; Van der Heyden, Jan; van Kleef, Monique; Lo, Rob; Versmissen, Jorie; Moelker, Adriaan; Kroon, Abraham; Reuter, Hannes; Ansel, Gary; Stone, Gregg W.; Bates, Mark; CALM-FIM EUR Investigators.

In: Lancet, Vol. 390, No. 10113, 16.12.2017, p. 2655-2661.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Endovascular baroreflex amplification for resistant hypertension

T2 - a safety and proof-of-principle clinical study

AU - Spiering, Wilko

AU - Williams, Bryan

AU - Van der Heyden, Jan

AU - van Kleef, Monique

AU - Lo, Rob

AU - Versmissen, Jorie

AU - Moelker, Adriaan

AU - Kroon, Abraham

AU - Reuter, Hannes

AU - Ansel, Gary

AU - Stone, Gregg W.

AU - Bates, Mark

AU - CALM-FIM EUR Investigators

PY - 2017/12/16

Y1 - 2017/12/16

KW - ACTIVATION THERAPY

KW - RENAL DENERVATION

KW - CONTROLLED-TRIAL

KW - BLOOD-PRESSURE

KW - DOUBLE-BLIND

KW - STIMULATION

KW - PLACEBO

KW - DISEASE

U2 - 10.1016/S0140-6736(17)32337-1

DO - 10.1016/S0140-6736(17)32337-1

M3 - Article

VL - 390

SP - 2655

EP - 2661

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 10113

ER -

Access to Document

10.1016/S0140-6736(17)32337-1